Abstract
Purpose
To investigate whether or not intermittent hypoxia (IH), the main characteristic of obstructive sleep apnea (OSA) may affect the myofibroblast differentiation and extracellular matrix (ECM) production of lung fibroblast through the HIF-1α-TGF-β/Smad pathway and assess the interventional role of a HIF-1α inhibitor, 2-methoxyestradiol (2-ME2).
Method
The human lung fibroblast MRC5 cells were exposed to normoxia or IH conditions, and the expression of myofibroblast differentiation marker α-smooth muscle actin (α-SMA) and ECM protein collagen I were evaluated. To clarify the underlying mechanism, the expression level of HIF-1α, TGF-β, and p-Smads/Smads were measured and the effects of inhibiting HIF-1α with 2-ME2 on the α-SMA expression level and ECM production through the TGF-β/Smad pathway were assessed. Si HIF-1α was applied to genetically inhibit HIF-1α in MRC5 cells, and the related proteins were assessed.
Results
IH increased the protein and mRNA expression of Collagen I and α-SMA of MRC5 cells in a time-dependent manner. IH activated the protein and mRNA level of HIF-1α and TGF-β and increased the phosphorylation of Smad2/Smad3 of MRC5 cells in a time-dependent manner. 2-ME2 inhibited the activation of HIF-1α induced by IH and decreased overexpression of TGF-β, p-Smad2/Smad2, and p-Smad3/Smad3, which in turn partially reversed the upregulation of α-SMA and Collagen I induced by IH in MRC5 cells. When HIF-1α was successfully silenced by si-HIF-1α, upregulation of TGF-β induced by intermittent hypoxia was partially decreased.
Conclusions
This study showed that IH contributes to myofibroblast differentiation and excessive ECM production of MRC5 cells through activation of the HIF-1α-TGF-β/Smad pathway. 2-ME2 partially attenuated myofibroblast differentiation induced by IH by inhibiting the HIF-1α-TGF-β/Smad pathway.
Similar content being viewed by others
Data availability
Data available on request from the authors.
References
Zamarron C, García Paz V, Riveiro A (2008) Obstructive sleep apnea syndrome is a systemic disease. Current evidence. Eur J Intern Med 19:390–398
Köktürk O, Ciftçi B (2003) Overlap syndrome. Tuberkuloz ve Toraks 51:333–48
Prasad B, Nyenhuis SM, Imayama I, Siddiqi A, Teodorescu M (2020) Asthma and obstructive sleep apnea overlap: what has the evidence taught us? Am J Respir Crit Care Med 201:1345–1357
Ioachimescu OC, Janocko NJ, Ciavatta MM, Howard M, Warnock MV (2020) Obstructive lung disease and obstructive sleep apnea (OLDOSA) cohort study: 10-year assessment. J Clin Sleep Med: JCSM: Off Publ Am Acad Sleep Med 16:267–277
Schiza SE, Bouloukaki I, Bolaki M, Antoniou KM (2020) Obstructive sleep apnea in pulmonary fibrosis. Curr Opin Pulm Med 26:443–448
Hirota N, Martin JG (2013) Mechanisms of airway remodeling. Chest 144:1026–1032
Xu XM, Yao D, Cai XD, Ding C, Lin QD, Wang LX et al (2015) Effect of chronic continual- and intermittent hypoxia-induced systemic inflammation on the cardiovascular system in rats. Sleep Breathing = Schlaf Atmung 19:677–84
Song S, Tan J, Miao Y, Zhang Q (2017) Effect of different levels of intermittent hypoxia on autophagy of hippocampal neurons. Sleep Breathing = Schlaf Atmung 21:791–8
Huang H, Jiang X, Dong Y, Zhang X, Ding N, Liu J et al (2014) Adiponectin alleviates genioglossal mitochondrial dysfunction in rats exposed to intermittent hypoxia. PLoS One 9:e109284
Wu J, Li P, Wu X, Chen W (2015) Chronic intermittent hypoxia decreases pain sensitivity and increases the expression of HIF1alpha and opioid receptors in experimental rats. Sleep Breathing = Schlaf Atmung 19:561–8
Hu B, Phan SH (2013) Myofibroblasts. Curr Opin Rheumatol 25:71–77
Lee JW, Bae SH, Jeong JW, Kim SH, Kim KW (2004) Hypoxia-inducible factor (HIF-1)alpha: its protein stability and biological functions. Exp Mol Med 36:1–12
Prabhakar NR, Peng YJ, Nanduri J (2020) Hypoxia-inducible factors and obstructive sleep apnea. J Clin Investig 130:5042–5051
Aquino-Gálvez A, González-Ávila G, Jiménez-Sánchez LL, Maldonado-Martínez HA, Cisneros J, Toscano-Marquez F et al (2019) Dysregulated expression of hypoxia-inducible factors augments myofibroblasts differentiation in idiopathic pulmonary fibrosis. Respir Res 20:130
Lei R, Li J, Liu F, Li W, Zhang S, Wang Y et al (2019) HIF-1α promotes the keloid development through the activation of TGF-β/Smad and TLR4/MyD88/NF-κB pathways. Cell Cycle (Georgetown, Tex) 18:3239–3250
Massagué J (2012) TGFβ signalling in context. Nat Rev Mol Cell Biol 13:616–630
Morikawa M, Derynck R, Miyazono K (2016) TGF-β and the TGF-β family: context-dependent roles in cell and tissue physiology. Cold Spring Harbor Perspect Biol 8:a021873
Carreras A, Kayali F, Zhang J, Hirotsu C, Wang Y, Gozal D (2012) Metabolic effects of intermittent hypoxia in mice: steady versus high-frequency applied hypoxia daily during the rest period. Am J Physiol Regul Integr Comp Physiol 303:R700–R709
ten Brinke A, Sterk PJ, Masclee AA, Spinhoven P, Schmidt JT, Zwinderman AH et al (2005) Risk factors of frequent exacerbations in difficult-to-treat asthma. Eur Respir J 26:812–818
McNicholas WT (2017) COPD-OSA overlap syndrome: evolving evidence regarding epidemiology, clinical consequences, and management. Chest 152:1318–1326
Hough KP, Curtiss ML, Blain TJ, Liu RM, Trevor J, Deshane JS et al (2020) Airway remodeling in asthma. Front Med 7:191
Plante S, Semlali A, Joubert P, Bissonnette E, Laviolette M, Hamid Q et al (2006) Mast cells regulate procollagen I (alpha 1) production by bronchial fibroblasts derived from subjects with asthma through IL-4/IL-4 delta 2 ratio. J Allergy Clin Immunol 117:1321–1327
Dewan NA, Nieto FJ, Somers VK (2015) Intermittent hypoxemia and OSA: implications for comorbidities. Chest 147:266–274
Li Y, Zheng JY, Liu JQ, Yang J, Liu Y, Wang C et al (2016) Succinate/NLRP3 inflammasome induces synovial fibroblast activation: therapeutical effects of clematichinenoside AR on arthritis. Front Immunol 7:532
Xie N, Tan Z, Banerjee S, Cui H, Ge J, Liu RM et al (2015) Glycolytic reprogramming in myofibroblast differentiation and lung fibrosis. Am J Respir Crit Care Med 192:1462–1474
Goodwin J, Choi H, Hsieh MH, Neugent ML, Ahn JM, Hayenga HN et al (2018) Targeting hypoxia-inducible factor-1α/pyruvate dehydrogenase kinase 1 axis by dichloroacetate suppresses bleomycin-induced pulmonary fibrosis. Am J Respir Cell Mol Biol 58:216–231
Kumar BS, Raghuvanshi DS, Hasanain M, Alam S, Sarkar J, Mitra K et al (2016) Recent advances in chemistry and pharmacology of 2-methoxyestradiol: an anticancer investigational drug. Steroids 110:9–34
Fotsis T, Zhang Y, Pepper MS, Adlercreutz H, Montesano R, Nawroth PP et al (1994) The endogenous oestrogen metabolite 2-methoxyoestradiol inhibits angiogenesis and suppresses tumour growth. Nature 368:237–239
Zhou X, Liu C, Lu J, Zhu L, Li M (2018) 2-Methoxyestradiol inhibits hypoxia-induced scleroderma fibroblast collagen synthesis by phosphatidylinositol 3-kinase/Akt/mTOR signalling. Rheumatology (Oxford) 57:1675–1684
Huerta-Yepez S, Baay-Guzman GJ, Garcia-Zepeda R, Hernandez-Pando R, Vega MI, Gonzalez-Bonilla C et al (2008) 2-Methoxyestradiol (2-ME) reduces the airway inflammation and remodeling in an experimental mouse model. Clin Immunol (Orlando, Fla) 129:313–324
Funding
Funding for this study included grants from the Chinese National Natural Science Foundation (Nos. 81970084 and 81670084), Chinese National Key Research and Development Program (No. 2016YFC1304502), and the Tianjin Key Research and Development Program (No. 20YFZCSY00390).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Ethical approval
No experiments with participants or animals were performed in this study.
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Liang, M., Si, L., Yu, Z. et al. Intermittent hypoxia induces myofibroblast differentiation and extracellular matrix production of MRC5s via HIF-1α-TGF-β/Smad pathway. Sleep Breath 28, 291–300 (2024). https://doi.org/10.1007/s11325-023-02889-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11325-023-02889-y